BeOne Medicines Ltd. 10-Q filing
Filed 2025-11-06 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001628280-25-049824
- Form type
- 10-Q
- CIK
- 0001651308
- Primary document
- https://www.sec.gov/Archives/edgar/data/1651308/000162828025049824/bgne-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BeOne Medicines Ltd..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $3.8B | - | - |
| Gross Profit | $3.3B | - | - |
| Operating Income | $262.1M | - | - |
| Net Income | $220.4M | - | - |
| Eps Basic | 0.16 | - | - |
| Eps Diluted | 0.15 | - | - |
| Cash And Equivalents | $4.0B | - | - |
| Total Assets | $7.6B | - | - |
| Total Liabilities | $3.5B | - | - |
| Shareholders Equity | $4.1B | - | - |
| Operating Cash Flow | $710.2M | - | - |
| Capital Expenditures | $148.3M | - | - |